Osterborg, A., Wierda, W., Mayer, J., Hess, G., Hillmen, P., Schetelig, J., . . . Dyer, M. (2015). Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients. British journal of haematology, 170(1), 40. https://doi.org/10.1111/bjh.13380
Chicago-referens (17:e uppl.)Osterborg, A., et al. "Ofatumumab Retreatment and Maintenance in Fludarabine-refractory Chronic Lymphocytic Leukaemia Patients." British Journal of Haematology 170, no. 1 (2015): 40. https://doi.org/10.1111/bjh.13380.
MLA-referens (9:e uppl.)Osterborg, A., et al. "Ofatumumab Retreatment and Maintenance in Fludarabine-refractory Chronic Lymphocytic Leukaemia Patients." British Journal of Haematology, vol. 170, no. 1, 2015, p. 40, https://doi.org/10.1111/bjh.13380.
